AN1
Click for more information
0.00% 0.8¢ anagenics limited

Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received, page-340

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. occhi.di.falco
    326 Posts.
    lightbulb Created with Sketch. 82
    clock Created with Sketch.
    20/04/20
    11:22
    Post #: 44137879
    @Ozjin it is always nice to know who the new posters are and to better understand the modus operandi


    CDY Price at posting: 23.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NVU Nanoveu commences crucial benchmark testing for System-on-aChip (SoC) Semiconductor technology
right-arrow Created with Sketch.
NEWS What's causing the cost-of-living crisis, and how to navigate it
right-arrow Created with Sketch.
NEWS Bigtincan announces agreement with Investcorp AI Acquisition Corp. for Nasdaq listing, valuing the company at US$275M
right-arrow Created with Sketch.
NEWS Elixir signs MOU with AGIG to explore gas infrastructure development for Taroom Trough project
right-arrow Created with Sketch.
NEWS Exceptional test at Erregulla Deep-1 delivers strong flow rates with high pressure, indicating potential for greater output
right-arrow Created with Sketch.
NEWS Significant resource upgrade and maiden ore reserve established, highlighting growth potential at Kanmantoo Copper Mine
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $3.690M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.